{"SPADE_N_14012": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_N_14012", "Peptide Name": "Brevinin-1LTe (B1LTe, natural AMPs, frog, amphibians, animals; XXU; 1S=S, UCSS1a; variants: brevinin-1 analogue 5R)", "Source": "skin secretion, the broad-folded frog,Hylarana latouchii", "Family": "Not found", "Gene": "Not found", "Sequence": "FLGTVLKVAAKVLPAALCQIFKKC", "Sequence Length": 24, "UniProt Entry": "Ref", "Protein Existence": "Not found", "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Anti-MRSA", "Hemolytic", "Antibiofilm"], "Target Organism": "Not found", "Hemolytic Activity": "Not found", "Cytotoxicity": "Not found", "Binding Target": "Not found", "Linear/Cyclic": "Not found", "N-terminal Modification": "Not found", "C-terminal Modification": "Not found", "Stereochemistry": "Not found", "Structure Description": "Not found", "Formula": "Not found", "Mass": 2562.23, "PI": 9.7, "Hydrophobicity": 1.18, "Half Life": "Not found", "Function": "Not found", "Literature": [{"Author": "Zou W, Sun R, Yao A, Zhou M, Chen X, Ma C, Wang T, Jiang Y, Chen T, Shaw C, Wang L. 2023", "Reference": "Comput Struct Biotechnol J. 2023 Nov 19;21:5719-5737. doi: 10.1016/j.csbj.2023.11.031.PubMed", "Title": "A promising antibiotic candidate, brevinin-1 analogue 5R, against drug-resistant bacteria, with insights into its membrane-targeting mechanism"}], "Frequent Amino Acids": "AKL", "Absent Amino Acids": "DEHMNORSUWY", "Basic Residues": 4, "Acidic Residues": 0, "Hydrophobic Residues": 15, "Polar Residues": 15, "Positive Residues": 4, "Negative Residues": 0, "Net Charge": 4, "Comments": "Sequence analysis: APD analysis reveals that this sequence is highly similar (91.67%) toBrevinin-1LT2L=A=K: 17%; GRAVY: 1.179; M Wt: 2562.259; M formula: C121H205N29O27S2.Activity: active against S. aureus ATCC 6538 or MRSA (MIC 1-2 uM), E. faecalis NCTC \n12697 (MIC 2 uM), E. coli ATCC 8739 (MIC 2 uM), K. pneumoniae ATCC 43816 (MIC 32 uM), P. aeruginosa ATCC 9027 (MIC 16 uM), A. baumannii ATCC BAA 747 (MIC 4 uM). In addition, it's more potent in eradicating biofilms of Gram+ pathogens than Gram-.Antimicrobial robustness: NaCl-insensitive:S. aureus; KCl-insensitive:S. aureus; NH4Cl-insensitive:S. aureus; MgCl2-insensitive:S. aureus; CaCl2-insensitive:S. aureus; FeCl3-insensitive:S. aureus; NaCl-sensitive:E. coli; KCl-insensitive:E. coli; NH4Cl-insensitive:E. coli; MgCl2-insensitive:E. coli; CaCl2-sensitive:E. coli; FeCl3-insensitive:E. coli;Toxicity: human RBC: HC50 6.4 uM, highly hemolytic.SAR: incorporation of D-amino acids and arginine increased peptide cell selectivity.", "Similar Sequences": [{"SPADE_ID": "SPADE_UN_25908", "Similarity": 1.0, "Sequence": "FLGTVLKVAAKVLPAALCQIFKKC"}, {"SPADE_ID": "SPADE_UN_25909", "Similarity": 0.9583333333333334, "Sequence": "FLGTVLKVLAKVLPAALCQIFKKC"}, {"SPADE_ID": "SPADE_UN_25910", "Similarity": 0.9166666666666666, "Sequence": "FLGTVLKVLLKVLPAALCQIFKKC"}]}}}